Trial Outcomes & Findings for Patient Outcomes and Gingival Blood Flow Using Laser Doppler Flowmetry Following the Use of Episil on Free Gingival Graft Donor Sites (NCT NCT03350724)
NCT ID: NCT03350724
Last Updated: 2018-04-17
Results Overview
Postoperative pain will be determined by the subjects recording their postoperative pain threshold using a Visual Analog Scale with scores from 1 to 10, with 1 indicating minimal pain and 10 indicating severe pain. If no pain is present, a score of 0 will be given. The levels of postoperative pain will be classified as none to minimum if the score is "0 to 3," moderate for "4 to 6," and severe for "7 to 10." None to minimal pain will mean little or no discomfort; moderate is any pain that bothers the subject and mildly affects normal function; and severe will be considered any pain that will not be tolerated and may even disrupt the subject's daily functions.
COMPLETED
NA
34 participants
1 day postoperatively
2018-04-17
Participant Flow
Participant milestones
| Measure |
Episil Wound Dressing
Episil is a wound dressing material intended for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. episil is an oromucosal liquid that transforms in situ to a bioadhesive oromucosal gel by uptake of small amounts of aqueous fluid.
|
PeriAcryl90 Wound Dressing
PeriAcryl90 is a cyanoacrylate wound dressing.
|
|---|---|---|
|
Overall Study
STARTED
|
17
|
17
|
|
Overall Study
COMPLETED
|
17
|
17
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Patient Outcomes and Gingival Blood Flow Using Laser Doppler Flowmetry Following the Use of Episil on Free Gingival Graft Donor Sites
Baseline characteristics by cohort
| Measure |
Episil Wound Dressing
n=17 Participants
Episil is a wound dressing material intended for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. episil is an oromucosal liquid that transforms in situ to a bioadhesive oromucosal gel by uptake of small amounts of aqueous fluid.
|
PeriAcryl90 Wound Dressing
n=17 Participants
PeriAcryl90 is a cyanoacrylate wound dressing.
|
Total
n=34 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
46.5 years
STANDARD_DEVIATION 17.2 • n=5 Participants
|
47.1 years
STANDARD_DEVIATION 15.5 • n=7 Participants
|
46.8 years
STANDARD_DEVIATION 16.4 • n=5 Participants
|
|
Sex: Female, Male
Female
|
9 Participants
n=5 Participants
|
13 Participants
n=7 Participants
|
22 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
8 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
12 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
2 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
1 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
14 Participants
n=5 Participants
|
16 Participants
n=7 Participants
|
30 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
17 Participants
n=5 Participants
|
17 Participants
n=7 Participants
|
34 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 1 day postoperativelyPostoperative pain will be determined by the subjects recording their postoperative pain threshold using a Visual Analog Scale with scores from 1 to 10, with 1 indicating minimal pain and 10 indicating severe pain. If no pain is present, a score of 0 will be given. The levels of postoperative pain will be classified as none to minimum if the score is "0 to 3," moderate for "4 to 6," and severe for "7 to 10." None to minimal pain will mean little or no discomfort; moderate is any pain that bothers the subject and mildly affects normal function; and severe will be considered any pain that will not be tolerated and may even disrupt the subject's daily functions.
Outcome measures
| Measure |
Episil Wound Dressing
n=17 Participants
Episil is a wound dressing material intended for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. episil is an oromucosal liquid that transforms in situ to a bioadhesive oromucosal gel by uptake of small amounts of aqueous fluid.
|
PeriAcryl90 Wound Dressing
n=17 Participants
PeriAcryl90 is a cyanoacrylate wound dressing.
|
|---|---|---|
|
Postoperative Pain as Assessed by Number of Participants With a Score of 0-3 (no to Minimal Pain) on a Visual Analog Scale
|
12 Participants
|
6 Participants
|
PRIMARY outcome
Timeframe: 2 days postoperativelyPostoperative pain will be determined by the subjects recording their postoperative pain threshold using a Visual Analog Scale with scores from 1 to 10, with 1 indicating minimal pain and 10 indicating severe pain. If no pain is present, a score of 0 will be given. The levels of postoperative pain will be classified as none to minimum if the score is "0 to 3," moderate for "4 to 6," and severe for "7 to 10." None to minimal pain will mean little or no discomfort; moderate is any pain that bothers the subject and mildly affects normal function; and severe will be considered any pain that will not be tolerated and may even disrupt the subject's daily functions.
Outcome measures
| Measure |
Episil Wound Dressing
n=17 Participants
Episil is a wound dressing material intended for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. episil is an oromucosal liquid that transforms in situ to a bioadhesive oromucosal gel by uptake of small amounts of aqueous fluid.
|
PeriAcryl90 Wound Dressing
n=17 Participants
PeriAcryl90 is a cyanoacrylate wound dressing.
|
|---|---|---|
|
Postoperative Pain as Assessed by Number of Participants With a Score of 0-3 (no to Minimal Pain) on a Visual Analog Scale
|
13 Participants
|
7 Participants
|
PRIMARY outcome
Timeframe: 3 days postoperativelyPostoperative pain will be determined by the subjects recording their postoperative pain threshold using a Visual Analog Scale with scores from 1 to 10, with 1 indicating minimal pain and 10 indicating severe pain. If no pain is present, a score of 0 will be given. The levels of postoperative pain will be classified as none to minimum if the score is "0 to 3," moderate for "4 to 6," and severe for "7 to 10." None to minimal pain will mean little or no discomfort; moderate is any pain that bothers the subject and mildly affects normal function; and severe will be considered any pain that will not be tolerated and may even disrupt the subject's daily functions.
Outcome measures
| Measure |
Episil Wound Dressing
n=17 Participants
Episil is a wound dressing material intended for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. episil is an oromucosal liquid that transforms in situ to a bioadhesive oromucosal gel by uptake of small amounts of aqueous fluid.
|
PeriAcryl90 Wound Dressing
n=17 Participants
PeriAcryl90 is a cyanoacrylate wound dressing.
|
|---|---|---|
|
Postoperative Pain as Assessed by Number of Participants With a Score of 0-3 (no to Minimal Pain) on a Visual Analog Scale
|
14 Participants
|
8 Participants
|
PRIMARY outcome
Timeframe: 5 days postoperativelyPostoperative pain will be determined by the subjects recording their postoperative pain threshold using a Visual Analog Scale with scores from 1 to 10, with 1 indicating minimal pain and 10 indicating severe pain. If no pain is present, a score of 0 will be given. The levels of postoperative pain will be classified as none to minimum if the score is "0 to 3," moderate for "4 to 6," and severe for "7 to 10." None to minimal pain will mean little or no discomfort; moderate is any pain that bothers the subject and mildly affects normal function; and severe will be considered any pain that will not be tolerated and may even disrupt the subject's daily functions.
Outcome measures
| Measure |
Episil Wound Dressing
n=17 Participants
Episil is a wound dressing material intended for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. episil is an oromucosal liquid that transforms in situ to a bioadhesive oromucosal gel by uptake of small amounts of aqueous fluid.
|
PeriAcryl90 Wound Dressing
n=17 Participants
PeriAcryl90 is a cyanoacrylate wound dressing.
|
|---|---|---|
|
Postoperative Pain as Assessed by Number of Participants With a Score of 0-3 (no to Minimal Pain) on a Visual Analog Scale
|
11 Participants
|
8 Participants
|
PRIMARY outcome
Timeframe: 7 days postoperativelyPostoperative pain will be determined by the subjects recording their postoperative pain threshold using a Visual Analog Scale with scores from 1 to 10, with 1 indicating minimal pain and 10 indicating severe pain. If no pain is present, a score of 0 will be given. The levels of postoperative pain will be classified as none to minimum if the score is "0 to 3," moderate for "4 to 6," and severe for "7 to 10." None to minimal pain will mean little or no discomfort; moderate is any pain that bothers the subject and mildly affects normal function; and severe will be considered any pain that will not be tolerated and may even disrupt the subject's daily functions.
Outcome measures
| Measure |
Episil Wound Dressing
n=17 Participants
Episil is a wound dressing material intended for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. episil is an oromucosal liquid that transforms in situ to a bioadhesive oromucosal gel by uptake of small amounts of aqueous fluid.
|
PeriAcryl90 Wound Dressing
n=17 Participants
PeriAcryl90 is a cyanoacrylate wound dressing.
|
|---|---|---|
|
Postoperative Pain as Assessed by Number of Participants With a Score of 0-3 (no to Minimal Pain) on a Visual Analog Scale
|
11 Participants
|
9 Participants
|
PRIMARY outcome
Timeframe: 10 days postoperativelyPostoperative pain will be determined by the subjects recording their postoperative pain threshold using a Visual Analog Scale with scores from 1 to 10, with 1 indicating minimal pain and 10 indicating severe pain. If no pain is present, a score of 0 will be given. The levels of postoperative pain will be classified as none to minimum if the score is "0 to 3," moderate for "4 to 6," and severe for "7 to 10." None to minimal pain will mean little or no discomfort; moderate is any pain that bothers the subject and mildly affects normal function; and severe will be considered any pain that will not be tolerated and may even disrupt the subject's daily functions.
Outcome measures
| Measure |
Episil Wound Dressing
n=17 Participants
Episil is a wound dressing material intended for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. episil is an oromucosal liquid that transforms in situ to a bioadhesive oromucosal gel by uptake of small amounts of aqueous fluid.
|
PeriAcryl90 Wound Dressing
n=17 Participants
PeriAcryl90 is a cyanoacrylate wound dressing.
|
|---|---|---|
|
Postoperative Pain as Assessed by Number of Participants With a Score of 0-3 (no to Minimal Pain) on a Visual Analog Scale
|
13 Participants
|
15 Participants
|
PRIMARY outcome
Timeframe: 14 days postoperativelyPostoperative pain will be determined by the subjects recording their postoperative pain threshold using a Visual Analog Scale with scores from 1 to 10, with 1 indicating minimal pain and 10 indicating severe pain. If no pain is present, a score of 0 will be given. The levels of postoperative pain will be classified as none to minimum if the score is "0 to 3," moderate for "4 to 6," and severe for "7 to 10." None to minimal pain will mean little or no discomfort; moderate is any pain that bothers the subject and mildly affects normal function; and severe will be considered any pain that will not be tolerated and may even disrupt the subject's daily functions.
Outcome measures
| Measure |
Episil Wound Dressing
n=17 Participants
Episil is a wound dressing material intended for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. episil is an oromucosal liquid that transforms in situ to a bioadhesive oromucosal gel by uptake of small amounts of aqueous fluid.
|
PeriAcryl90 Wound Dressing
n=17 Participants
PeriAcryl90 is a cyanoacrylate wound dressing.
|
|---|---|---|
|
Postoperative Pain as Assessed by Number of Participants With a Score of 0-3 (no to Minimal Pain) on a Visual Analog Scale
|
17 Participants
|
16 Participants
|
PRIMARY outcome
Timeframe: 21 days postoperativelyPostoperative pain will be determined by the subjects recording their postoperative pain threshold using a Visual Analog Scale with scores from 1 to 10, with 1 indicating minimal pain and 10 indicating severe pain. If no pain is present, a score of 0 will be given. The levels of postoperative pain will be classified as none to minimum if the score is "0 to 3," moderate for "4 to 6," and severe for "7 to 10." None to minimal pain will mean little or no discomfort; moderate is any pain that bothers the subject and mildly affects normal function; and severe will be considered any pain that will not be tolerated and may even disrupt the subject's daily functions.
Outcome measures
| Measure |
Episil Wound Dressing
n=17 Participants
Episil is a wound dressing material intended for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. episil is an oromucosal liquid that transforms in situ to a bioadhesive oromucosal gel by uptake of small amounts of aqueous fluid.
|
PeriAcryl90 Wound Dressing
n=17 Participants
PeriAcryl90 is a cyanoacrylate wound dressing.
|
|---|---|---|
|
Postoperative Pain as Assessed by Number of Participants With a Score of 0-3 (no to Minimal Pain) on a Visual Analog Scale
|
17 Participants
|
17 Participants
|
PRIMARY outcome
Timeframe: 1 day postoperativelyPostoperative pain will be determined by the subjects recording the number of analgesic pills (Ibuprofen 600mg tablets) taken each day.
Outcome measures
| Measure |
Episil Wound Dressing
n=17 Participants
Episil is a wound dressing material intended for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. episil is an oromucosal liquid that transforms in situ to a bioadhesive oromucosal gel by uptake of small amounts of aqueous fluid.
|
PeriAcryl90 Wound Dressing
n=17 Participants
PeriAcryl90 is a cyanoacrylate wound dressing.
|
|---|---|---|
|
Postoperative Pain as Assessed by the Number of Analgesic Pills Taken Each Day
|
2 number of Ibuprofen 600mg tablets
Interval 1.0 to 3.0
|
3 number of Ibuprofen 600mg tablets
Interval 2.0 to 4.0
|
PRIMARY outcome
Timeframe: 2 days postoperativelyPostoperative pain will be determined by the subjects recording the number of analgesic pills (Ibuprofen 600mg tablets) taken each day.
Outcome measures
| Measure |
Episil Wound Dressing
n=17 Participants
Episil is a wound dressing material intended for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. episil is an oromucosal liquid that transforms in situ to a bioadhesive oromucosal gel by uptake of small amounts of aqueous fluid.
|
PeriAcryl90 Wound Dressing
n=17 Participants
PeriAcryl90 is a cyanoacrylate wound dressing.
|
|---|---|---|
|
Postoperative Pain as Assessed by the Number of Analgesic Pills Taken Each Day
|
2 number of Ibuprofen 600mg tablets
Interval 1.0 to 3.0
|
3 number of Ibuprofen 600mg tablets
Interval 2.0 to 4.0
|
PRIMARY outcome
Timeframe: 3 days postoperativelyPostoperative pain will be determined by the subjects recording the number of analgesic pills (Ibuprofen 600mg tablets) taken each day.
Outcome measures
| Measure |
Episil Wound Dressing
n=17 Participants
Episil is a wound dressing material intended for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. episil is an oromucosal liquid that transforms in situ to a bioadhesive oromucosal gel by uptake of small amounts of aqueous fluid.
|
PeriAcryl90 Wound Dressing
n=17 Participants
PeriAcryl90 is a cyanoacrylate wound dressing.
|
|---|---|---|
|
Postoperative Pain as Assessed by the Number of Analgesic Pills Taken Each Day
|
2 number of Ibuprofen 600mg tablets
Interval 1.0 to 2.0
|
2 number of Ibuprofen 600mg tablets
Interval 2.0 to 4.0
|
PRIMARY outcome
Timeframe: 5 days postoperativelyPostoperative pain will be determined by the subjects recording the number of analgesic pills (Ibuprofen 600mg tablets) taken each day.
Outcome measures
| Measure |
Episil Wound Dressing
n=17 Participants
Episil is a wound dressing material intended for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. episil is an oromucosal liquid that transforms in situ to a bioadhesive oromucosal gel by uptake of small amounts of aqueous fluid.
|
PeriAcryl90 Wound Dressing
n=17 Participants
PeriAcryl90 is a cyanoacrylate wound dressing.
|
|---|---|---|
|
Postoperative Pain as Assessed by the Number of Analgesic Pills Taken Each Day
|
2 number of Ibuprofen 600mg tablets
Interval 1.0 to 3.0
|
2 number of Ibuprofen 600mg tablets
Interval 1.0 to 3.0
|
PRIMARY outcome
Timeframe: 7 days postoperativelyPostoperative pain will be determined by the subjects recording the number of analgesic pills (Ibuprofen 600mg tablets) taken each day.
Outcome measures
| Measure |
Episil Wound Dressing
n=17 Participants
Episil is a wound dressing material intended for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. episil is an oromucosal liquid that transforms in situ to a bioadhesive oromucosal gel by uptake of small amounts of aqueous fluid.
|
PeriAcryl90 Wound Dressing
n=17 Participants
PeriAcryl90 is a cyanoacrylate wound dressing.
|
|---|---|---|
|
Postoperative Pain as Assessed by the Number of Analgesic Pills Taken Each Day
|
2 number of Ibuprofen 600mg tablets
Interval 1.0 to 3.0
|
2 number of Ibuprofen 600mg tablets
Interval 1.0 to 3.0
|
PRIMARY outcome
Timeframe: 10 days postoperativelyPostoperative pain will be determined by the subjects recording the number of analgesic pills (Ibuprofen 600mg tablets) taken each day.
Outcome measures
| Measure |
Episil Wound Dressing
n=17 Participants
Episil is a wound dressing material intended for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. episil is an oromucosal liquid that transforms in situ to a bioadhesive oromucosal gel by uptake of small amounts of aqueous fluid.
|
PeriAcryl90 Wound Dressing
n=17 Participants
PeriAcryl90 is a cyanoacrylate wound dressing.
|
|---|---|---|
|
Postoperative Pain as Assessed by the Number of Analgesic Pills Taken Each Day
|
1 number of Ibuprofen 600mg tablets
Interval 0.0 to 2.0
|
1 number of Ibuprofen 600mg tablets
Interval 0.0 to 2.0
|
PRIMARY outcome
Timeframe: 14 days postoperativelyPostoperative pain will be determined by the subjects recording the number of analgesic pills (Ibuprofen 600mg tablets) taken each day.
Outcome measures
| Measure |
Episil Wound Dressing
n=17 Participants
Episil is a wound dressing material intended for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. episil is an oromucosal liquid that transforms in situ to a bioadhesive oromucosal gel by uptake of small amounts of aqueous fluid.
|
PeriAcryl90 Wound Dressing
n=17 Participants
PeriAcryl90 is a cyanoacrylate wound dressing.
|
|---|---|---|
|
Postoperative Pain as Assessed by the Number of Analgesic Pills Taken Each Day
|
0 number of Ibuprofen 600mg tablets
Interval 0.0 to 0.0
|
1 number of Ibuprofen 600mg tablets
Interval 0.0 to 1.0
|
PRIMARY outcome
Timeframe: 21 days postoperativelyPostoperative pain will be determined by the subjects recording the number of analgesic pills taken each day.
Outcome measures
| Measure |
Episil Wound Dressing
n=17 Participants
Episil is a wound dressing material intended for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. episil is an oromucosal liquid that transforms in situ to a bioadhesive oromucosal gel by uptake of small amounts of aqueous fluid.
|
PeriAcryl90 Wound Dressing
n=17 Participants
PeriAcryl90 is a cyanoacrylate wound dressing.
|
|---|---|---|
|
Postoperative Pain as Assessed by the Number of Analgesic Pills Taken Each Day
|
0 number of Ibuprofen 600mg tablets
Interval 0.0 to 0.0
|
0 number of Ibuprofen 600mg tablets
Interval 0.0 to 0.0
|
SECONDARY outcome
Timeframe: baseline (on the day of surgery before surgery)The laser Doppler flowmetry (LDF) technique to measure the blood perfusion of the free gingival graft (FGG) donor site. The value reported is blood flow at the FGG donor site (operated site) minus blood flow at the contralateral side of the palate (non-operated site). Perfusion Units (PU) are reported, which is blood flow through a given volume or mass of tissue with the unit of measure mL/100g/min.
Outcome measures
| Measure |
Episil Wound Dressing
n=17 Participants
Episil is a wound dressing material intended for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. episil is an oromucosal liquid that transforms in situ to a bioadhesive oromucosal gel by uptake of small amounts of aqueous fluid.
|
PeriAcryl90 Wound Dressing
n=17 Participants
PeriAcryl90 is a cyanoacrylate wound dressing.
|
|---|---|---|
|
Gingival Blood Flow as Measured Laser Doppler Flometry (LDF)
|
-34.7 mL/100g/min
Standard Deviation 126.7
|
5.3 mL/100g/min
Standard Deviation 36.0
|
SECONDARY outcome
Timeframe: 3 days postoperativelyPopulation: One patient was not able to have Day 3 laser Doppler flowmetry (LDF) readings because of a death in the family, and this patient had to travel out of town for several days.
The laser Doppler flowmetry (LDF) technique to measure the blood perfusion of the FGG donor site. The value reported is blood flow at the FGG donor site (operated site) minus blood flow at the contralateral side of the palate (non-operated site). Perfusion Units (PU) are reported, which is blood flow through a given volume or mass of tissue with the unit of measure mL/100g/min.
Outcome measures
| Measure |
Episil Wound Dressing
n=16 Participants
Episil is a wound dressing material intended for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. episil is an oromucosal liquid that transforms in situ to a bioadhesive oromucosal gel by uptake of small amounts of aqueous fluid.
|
PeriAcryl90 Wound Dressing
n=16 Participants
PeriAcryl90 is a cyanoacrylate wound dressing.
|
|---|---|---|
|
Gingival Blood Flow as Measured Laser Doppler Flowmetry (LDF)
|
42.5 mL/100g/min
Standard Deviation 132.1
|
50.0 mL/100g/min
Standard Deviation 152.3
|
SECONDARY outcome
Timeframe: 7 days postoperativelyThe laser Doppler flowmetry (LDF) technique to measure the blood perfusion of the FGG donor site. The value reported is blood flow at the FGG donor site (operated site) minus blood flow at the contralateral side of the palate (non-operated site). Perfusion Units (PU) are reported, which is blood flow through a given volume or mass of tissue with the unit of measure mL/100g/min.
Outcome measures
| Measure |
Episil Wound Dressing
n=17 Participants
Episil is a wound dressing material intended for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. episil is an oromucosal liquid that transforms in situ to a bioadhesive oromucosal gel by uptake of small amounts of aqueous fluid.
|
PeriAcryl90 Wound Dressing
n=17 Participants
PeriAcryl90 is a cyanoacrylate wound dressing.
|
|---|---|---|
|
Gingival Blood Flow as Measured Laser Doppler Flowmetry (LDF)
|
203.9 mL/100g/min
Standard Deviation 219.8
|
169.0 mL/100g/min
Standard Deviation 197.7
|
SECONDARY outcome
Timeframe: 14 days postoperativelyThe laser Doppler flowmetry (LDF) technique to measure the blood perfusion of the FGG donor site. The value reported is blood flow at the FGG donor site (operated site) minus blood flow at the contralateral side of the palate (non-operated site). Perfusion Units (PU) are reported, which is blood flow through a given volume or mass of tissue with the unit of measure mL/100g/min.
Outcome measures
| Measure |
Episil Wound Dressing
n=17 Participants
Episil is a wound dressing material intended for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. episil is an oromucosal liquid that transforms in situ to a bioadhesive oromucosal gel by uptake of small amounts of aqueous fluid.
|
PeriAcryl90 Wound Dressing
n=17 Participants
PeriAcryl90 is a cyanoacrylate wound dressing.
|
|---|---|---|
|
Gingival Blood Flow as Measured Laser Doppler Flowmetry (LDF)
|
266.3 mL/100g/min
Standard Deviation 242.9
|
262.8 mL/100g/min
Standard Deviation 248.1
|
SECONDARY outcome
Timeframe: 21 days postoperativelyThe laser Doppler flowmetry (LDF) technique to measure the blood perfusion of the FGG donor site. The value reported is blood flow at the FGG donor site (operated site) minus blood flow at the contralateral side of the palate (non-operated site). Perfusion Units (PU) are reported, which is blood flow through a given volume or mass of tissue with the unit of measure mL/100g/min.
Outcome measures
| Measure |
Episil Wound Dressing
n=17 Participants
Episil is a wound dressing material intended for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. episil is an oromucosal liquid that transforms in situ to a bioadhesive oromucosal gel by uptake of small amounts of aqueous fluid.
|
PeriAcryl90 Wound Dressing
n=17 Participants
PeriAcryl90 is a cyanoacrylate wound dressing.
|
|---|---|---|
|
Gingival Blood Flow as Measured Laser Doppler Flowmetry (LDF)
|
151.2 mL/100g/min
Standard Deviation 227.1
|
85.3 mL/100g/min
Standard Deviation 184.7
|
SECONDARY outcome
Timeframe: 3 days postoperativelyThe non-invasive peroxide test is based on the principle that if the epithelium is discontinuous, the H2O2 diffuses into the connective tissue; the enzyme catalase acts on H2O2 to release water and oxygen: this is clinically shown by the production of bubbles on the wound. 3% H2O2 will be applied to the FGG donor site with a syringe and the appearance of bubbles will be recorded as a dichotomous variable (yes/no).
Outcome measures
| Measure |
Episil Wound Dressing
n=17 Participants
Episil is a wound dressing material intended for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. episil is an oromucosal liquid that transforms in situ to a bioadhesive oromucosal gel by uptake of small amounts of aqueous fluid.
|
PeriAcryl90 Wound Dressing
n=17 Participants
PeriAcryl90 is a cyanoacrylate wound dressing.
|
|---|---|---|
|
Number of Participants With Re-epithelialization of the FGG Donor Site as Indicated by a Non-invasive Peroxide Test
|
1 Participants
|
0 Participants
|
SECONDARY outcome
Timeframe: 7 days postoperativelyThe non-invasive peroxide test is based on the principle that if the epithelium is discontinuous, the H2O2 diffuses into the connective tissue; the enzyme catalase acts on H2O2 to release water and oxygen: this is clinically shown by the production of bubbles on the wound. 3% H2O2 will be applied to the FGG donor site with a syringe and the appearance of bubbles will be recorded as a dichotomous variable (yes/no).
Outcome measures
| Measure |
Episil Wound Dressing
n=17 Participants
Episil is a wound dressing material intended for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. episil is an oromucosal liquid that transforms in situ to a bioadhesive oromucosal gel by uptake of small amounts of aqueous fluid.
|
PeriAcryl90 Wound Dressing
n=17 Participants
PeriAcryl90 is a cyanoacrylate wound dressing.
|
|---|---|---|
|
Number of Participants With Re-epithelialization of the FGG Donor Site as Indicated by a Non-invasive Peroxide Test
|
0 Participants
|
0 Participants
|
SECONDARY outcome
Timeframe: 14 days postoperativelyThe non-invasive peroxide test is based on the principle that if the epithelium is discontinuous, the H2O2 diffuses into the connective tissue; the enzyme catalase acts on H2O2 to release water and oxygen: this is clinically shown by the production of bubbles on the wound. 3% H2O2 will be applied to the FGG donor site with a syringe and the appearance of bubbles will be recorded as a dichotomous variable (yes/no).
Outcome measures
| Measure |
Episil Wound Dressing
n=17 Participants
Episil is a wound dressing material intended for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. episil is an oromucosal liquid that transforms in situ to a bioadhesive oromucosal gel by uptake of small amounts of aqueous fluid.
|
PeriAcryl90 Wound Dressing
n=17 Participants
PeriAcryl90 is a cyanoacrylate wound dressing.
|
|---|---|---|
|
Number of Participants With Re-epithelialization of the FGG Donor Site as Indicated by a Non-invasive Peroxide Test
|
0 Participants
|
0 Participants
|
SECONDARY outcome
Timeframe: 21 days postoperativelyThe non-invasive peroxide test is based on the principle that if the epithelium is discontinuous, the H2O2 diffuses into the connective tissue; the enzyme catalase acts on H2O2 to release water and oxygen: this is clinically shown by the production of bubbles on the wound. 3% H2O2 will be applied to the FGG donor site with a syringe and the appearance of bubbles will be recorded as a dichotomous variable (yes/no).
Outcome measures
| Measure |
Episil Wound Dressing
n=17 Participants
Episil is a wound dressing material intended for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. episil is an oromucosal liquid that transforms in situ to a bioadhesive oromucosal gel by uptake of small amounts of aqueous fluid.
|
PeriAcryl90 Wound Dressing
n=17 Participants
PeriAcryl90 is a cyanoacrylate wound dressing.
|
|---|---|---|
|
Number of Participants With Re-epithelialization of the FGG Donor Site as Indicated by a Non-invasive Peroxide Test
|
6 Participants
|
5 Participants
|
Adverse Events
Episil Wound Dressing
PeriAcryl90 Wound Dressing
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Jennifer James, DMD, MS
The University of Texas Health Science Center at Houston
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place